These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3904340)

  • 1. Early immunosuppressive effect of parenteral methylprednisolone in the treatment of multiple sclerosis.
    Durelli L; Baggio GF; Bergamasco B; Barile C; Cocito D; Delsedime M; Perla F; Riccio A; Bergamini L
    Acta Neurol (Napoli); 1985; 7(3-4):338-44. PubMed ID: 3904340
    [No Abstract]   [Full Text] [Related]  

  • 2. [Our experiences in the treatment of multiple sclerosis by intrathecal administration of methylprednisolone acetate and follow-up of the cerebrospinal fluid changes during this treatment].
    Jedlicka P; Kupka J; Kocinová F
    Cesk Neurol Neurochir; 1975 Dec; 38(6):338-45. PubMed ID: 1104205
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of treatment with Encorton (Polfa), Solu-Medrol and Encorton and Cyclophosphamide and Encorton on the production of immunoglobulin G in the central nervous system in multiple sclerosis].
    Ochudło S
    Wiad Lek; 1989 Dec; 41(23):1579-83. PubMed ID: 2669352
    [No Abstract]   [Full Text] [Related]  

  • 4. Intrathecal methylprednisolone acetate in multiple sclerosis treatment. Clinical evaluation.
    Mazzarello P; Poloni M; Piccolo G; Cosi V; Pinelli P
    Acta Neurol Belg; 1983; 83(4):190-6. PubMed ID: 6689244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose intravenous methylprednisolone in the treatment of multiple sclerosis: clinical-immunologic correlations.
    Durelli L; Cocito D; Riccio A; Barile C; Bergamasco B; Baggio GF; Perla F; Delsedime M; Gusmaroli G; Bergamini L
    Neurology; 1986 Feb; 36(2):238-43. PubMed ID: 3511404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Multiple sclerosis. Clinico-statistical results of therapy based on intrathecal methylprednisolone acetate].
    Sbarbaro V; Girelli Bruni E; Monaco V; Gasperini GF; Zardini GB; Brogi L
    Minerva Med; 1974 Sep; 65(65):3407-11. PubMed ID: 4479023
    [No Abstract]   [Full Text] [Related]  

  • 7. [Our contemporary experiences with the intrathecal treatment of multiple sclerosis using depot corticoids. II. Results in cerebrospinal fluid].
    Hrazdira CL; Mandzjuk B; Skálová M
    Cesk Neurol Neurochir; 1974 Sep; 37(5):293-300. PubMed ID: 4479029
    [No Abstract]   [Full Text] [Related]  

  • 8. [Our contemporary experiences with the intrathecal treatment of multiple sclerosis using depot corticoids. I. Clinical results].
    Hanák L; Zouhar A
    Cesk Neurol Neurochir; 1974 Sep; 37(5):287-92. PubMed ID: 4479028
    [No Abstract]   [Full Text] [Related]  

  • 9. Double-blind trial of dexamethasone versus methylprednisolone in multiple sclerosis acute relapses.
    La Mantia L; Eoli M; Milanese C; Salmaggi A; Dufour A; Torri V
    Eur Neurol; 1994; 34(4):199-203. PubMed ID: 7915989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind clinical trial of mitoxantrone versus methylprednisolone in relapsing, secondary progressive multiple sclerosis.
    van de Wyngaert FA; Beguin C; D'Hooghe MB; Dooms G; Lissoir F; Carton H; Sindic CJ
    Acta Neurol Belg; 2001 Dec; 101(4):210-6. PubMed ID: 11851027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Promising results with methylprednisolone in multiple sclerosis. Lack of patent rights makes drug industry less interested].
    Kling A; Dahlqvist R
    Lakartidningen; 2007 Jan 17-23; 104(3):128-30. PubMed ID: 17302117
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prospective evaluation of the effectiveness of high doses of methylprednisolone in multiple sclerosis].
    Wajgt A; Szczechowski L; Marczewska E; Grechuta M; Strzyzewska L; Gadomska B; Szyrocka-Szwed K
    Neurol Neurochir Pol; 1988; 22(3):188-94. PubMed ID: 3065667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind trial of transfer factor vs placebo in multiple sclerosis patients.
    Collins RC; Espinoza LR; Plank CR; Ebers GC; Rosenberg RA; Zabriskie JB
    Clin Exp Immunol; 1978 Jul; 33(1):1-11. PubMed ID: 361313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prospective assessment of combined treatment with high doses of intravenous methylprednisolone and long term administration of Isoprinosine in multiple sclerosis patients].
    Maciejek Z; Niezgodzińska-Maciejek A
    Neurol Neurochir Pol; 1993; 27(3):321-9. PubMed ID: 7694166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of multiple sclerosis using immunosuppression. Critical discussion of results].
    Hommes OR
    Ned Tijdschr Geneeskd; 1976 Mar; 120(10):424-30. PubMed ID: 765862
    [No Abstract]   [Full Text] [Related]  

  • 16. The treatment of multiple sclerosis with intrathecally administered methylprednisolone acetate.
    Ringer WA
    J Indiana State Med Assoc; 1968 Sep; 61(9):1213-5. PubMed ID: 5695699
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapeutic trials for multiple sclerosis.
    McKhann GM
    Ann Neurol; 1990 Jun; 27(6):589-90. PubMed ID: 2193612
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of worsening multiple sclerosis with mitoxantrone: a review.
    Fox EJ
    Clin Ther; 2006 Apr; 28(4):461-74. PubMed ID: 16750460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversible impaired memory induced by pulsed methylprednisolone in patients with MS.
    Uttner I; Müller S; Zinser C; Maier M; Süssmuth S; Claus A; Ostermann B; Elitok E; Ecker D; Brettschneider J; Gold R; Tumani H
    Neurology; 2005 Jun; 64(11):1971-3. PubMed ID: 15955958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 2. Laboratory results.
    Compston DA; Milligan NM; Hughes PJ; Gibbs J; McBroom V; Morgan BP; Campbell AK
    J Neurol Neurosurg Psychiatry; 1987 May; 50(5):517-22. PubMed ID: 2953865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.